Nigel Sheail

Venture Partner at Versant Ventures

Prior to joining Versant, Nigel was Global Head of Mergers & Acquisitions and Business Development & Licensing at Novartis, where he served as a member of the company’s senior leadership team. In that role, he was responsible for the execution of a broad range of healthcare deals spanning research and technology collaborations through to large M&A transactions. Prior to Novartis, Nigel was Head of Business Development and Licensing for Bayer Healthcare, and before that served as Head of Group M&A at Roche and Head of Licensing for its Pharma division.